Ozempic Lawsuit FAQs

What Types of Injuries Are the Plaintiffs in the Ozempic Lawsuit Reporting?

The plaintiffs in the Ozempic lawsuit all experienced significant health concerns while using this drug or shortly after discontinuing the medication. If you received a diagnosis of one of the following conditions while using Ozempic or after stopping the injections, you could be eligible.

The list of conditions includes:

• Blocked intestine (bowel obstruction) requiring hospitalization
• Gastric pacemaker or surgically implanted gastric stimulator
• Gastroparesis (stomach paralysis) with or without hospitalization
• Ileus (intestinal blockage) diagnosis before November 2022
• Malnutrition requiring hospitalization
• Non-arteritic anterior ischemic optic neuropathy (NAION)
• Pulmonary aspiration while under anesthesia or during surgery
• Sudden blurred vision
• Sudden color vision loss
• Sudden dark area or shadow in vision
• Sudden loss of vision in one or both eyes
• Wernicke’s encephalopathy

There is peer-reviewed research and many anecdotal tales linking these conditions with the dangerous drug class in question. Other conditions could be added to the lawsuit later if researchers identify additional risks.

Who Are the Liable Parties Named in the Ozempic Lawsuit?

The Ozempic multidistrict litigation names two companies as the defendants:

• Novo Nordisk: Maker of Ozempic, Wegovy, Rybelsus, Saxenda, and Victoza
• Eli Lilly and Company: Maker of Mounjaro, Trulicity, and Zepbound

These are the dangerous medications included in this lawsuit and the pharmaceutical companies accused of marketing these drugs without strong warnings despite knowing the risk of serious health concerns.

How Much Will It Cost Me to File an Ozempic Lawsuit?

Many potential plaintiffs hesitate to contact our team about their case because they do not believe they can afford to hire an Ozempic lawsuit lawyer. They want to hold the drug companies accountable and need compensation to cover their care costs, but they do not have the money to build the case and pay attorney’s fees.

There is good news if this describes you. Our law firm partners represent plaintiffs in these lawsuits with no upfront fees or costs. You will not need to pay a retainer or other upfront expenses. Instead, the attorney is paid only from the compensation they recover for you in your Ozempic case. You pay nothing unless you receive compensation.

Because this case is proceeding as a mass tort, the plaintiffs also share all of the costs of investigating the link between the drug and their symptoms. This allows the use of experts and specialists out of the price range for an individual navigating this process.

What Is the Ozempic Multidistrict Litigation?

The Ozempic lawsuit is a mass tort, where hundreds of plaintiffs’ cases are consolidated and treated as a single case for pretrial hearings and the discovery process. This case alleges that medications in the glucagon-like peptide-1 (GLP-1) receptor agonist class—including Ozempic—can cause serious health conditions and disease. According to the lawsuits, plaintiffs believe the drug companies were aware of these risks but failed to adequately warn consumers before they used the medications.

On February 5, 2024, the U.S. Judicial Panel on Multidistrict Litigation approved the formation of multidistrict litigation in this case. It consolidated the pending lawsuits into  MDL 3094 IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation. This case is underway in the U.S. District Court in the Eastern District of Pennsylvania. Judge Karen Spencer Marston is currently presiding.

Plaintiffs continue to file complaints and join the MDL, which is expected to grow quickly as more potential plaintiffs learn about their rights and legal options. In its August 2024 update, the U.S. Judicial Panel on Multidistrict Litigation reported 346 cases in mass torts.

How Much Is the Ozempic Lawsuit Settlement?

There have not been any settlement offers or agreements in the Ozempic MDL yet. The case is still in its earliest stages, having just consolidated in February 2024 and then facing slight delays when the presiding judge passed away in May. Judge Karen Spencer Marston took over in June and is ensuring the case is progressing as expected. However, there is no timeline for when settlements might happen if they occur.

Remember, cases in multidistrict litigation are still separate. This sets the process apart from a class action. Each plaintiff will negotiate their own settlement agreement in MDL 3094. This will allow them to recover compensation for their unique:

• Current and future medical care for their Ozempic injuries
• Lost income and reduced earning ability for lasting disabilities
• Related expenses
• Pain and suffering
• Other noneconomic damages

Other types of damages might be awarded or court-ordered, as well. This could include:

Punitive Damages

While punitive damages are not common, they could occur in an Ozempic lawsuit if the jury believes the company acted intentionally, fraudulently, or especially negligently.

Injunctive Relief

Sometimes, the court might order injunctive relief, or it might be a part of a settlement agreement. This is not monetary. Instead, it is an action the defendants agree to take to try to prevent similar issues in the future. For example, this could include altering their packaging, adding new warnings, or requiring closer monitoring of patients using the drugs.

What Is the Statute of Limitations for Filing an Ozempic Lawsuit?

There is no overarching deadline that one must meet to file an Ozempic lawsuit. At some point, the case will progress to settlements or dismissal, and no new cases will be filed. However, this is likely several years in the future.

The deadline that matters right now is the one set by your state for filing lawsuits based on dangerous drug injuries. Depending on your state’s laws, you could have between one year and six years to sue. Most states have a two-year or three-year timeline for these cases. The clock generally begins its countdown the day you receive a qualifying diagnosis.